SNTI
$0.92+0.02 (+2.14%)
Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf he...
Recent News
BC-Most Active Stocks
Nu Holdings Ltd. 29,941,575 16.73
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Galmed Pharmaceuticals (GLMD), 6,307% surge in interest CG Oncology (CGON), 3,377% surge in interest Chemomab Therapeutics (CMMB), 3,029% surge in interest BioCardia (BCDA), 1,244% surge in interest Senti Biosciences (SNTI), 1,175% surge in interest Tevogen Bio Holdings (TVGN), 332% surge in interest Regulus Therapeutics (RGLS), 223% surge in interest Spr
Senti Biosciences Pauses Enrollment in Hepatocellular Carcinoma Trial in China; Shares Fall
Senti Biosciences (SNTI) said Monday enrollment in the investigator-sponsored trial for SENTI-301A,